Eric D Eisenmann

19PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 25, 2026
Strain-dependent neuronal disposition and toxicity of paclitaxel in mice.

|Mar 02, 2026
Mechanisms Underlying Cedazuridine-Mediated Enhancement of Oral Decitabine Bioavailability.

Nadeen Anabtawi, Thomas Drabison, Alexander F Ham

|Aug 22, 2025
Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895.

Jack C Stromatt, Eman A Ahmed, Thomas Drabison

|Jun 25, 2025
A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years.

Eric D Eisenmann, Ronan Swords, Ying Huang

|Jan 08, 2025
Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport.

John Haynes, Arnav Joshi, Ross C Larue

|Aug 29, 2024
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen.

Thomas Drabison, Mike Boeckman, Yan Yang

Pageof 4

Frequent Collaborators

10 joint publications

Sharyn D Baker

8 joint publications

Alex Sparreboom

6 joint publications

Shuiying Hu

5 joint publications

Shelley Orwick